Anti-interleukin 17A therapy inhibits tumour necrosis factor-mediated bone loss by modulation of T cell balance

K Polzer, M Koenders, W Baum, A Patakas, I Mcinnes, L Joosten, G Schett, W van den Berg, J Zwerina
2010 Annals of the Rheumatic Diseases  
doi:10.1136/ard.2010.129593i fatcat:uodfj6cxqnhpvaeoo2npzil5wu